Besigliptin Tosylate is a DPP-4 inhibitor potentially for the treatment of type 2 diabetes. References: Liu X, Zhang LN, Feng Y, Zhang L, Qu H, Cao GQ, Leng Y. Acute and chronic administration of SHR117887, a novel and specific dipeptidyl peptidase-4 inhibitor, improves metabolic control in diabetic rodent models. Acta Pharmacol Sin. 2012 Aug;33(8):1013-22. doi: 10.1038/aps.2012.75. PubMed PMID: 22842733; PubMed Central PMCID: PMC4011329.

纯度：≥98%

CAS：1177460-72-8